 <h1>Perforomist Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>formoterol</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about formoterol. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Perforomist.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to formoterol: inhalation capsule, inhalation solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, formoterol (the active ingredient contained in Perforomist) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking formoterol:</p><p>
<i>More common</i>
</p><ul>
<li>Body aches or pain</li>
<li>chills</li>
<li>cough </li>
<li>difficulty with breathing</li>
<li>ear congestion</li>
<li>fever</li>
<li>headache</li>
<li>hoarseness</li>
<li>loss of voice</li>
<li>runny or stuffy nose</li>
<li>sneezing</li>
<li>sore throat</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Chest pain or discomfort</li>
<li>cough-producing mucous</li>
<li>dry throat</li>
<li>labored breathing</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>tender, swollen glands in the neck</li>
<li>tightness in the chest</li>
<li>trauma</li>
<li>trouble with swallowing</li>
<li>voice changes</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Decreased urine</li>
<li>dry mouth</li>
<li>fainting</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>increased thirst</li>
<li>loss of appetite</li>
<li>noisy breathing</li>
<li>seizures</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blurred vision</li>
<li>confusion</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>hives, itching, skin rash</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>sweating</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking formoterol:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Arm, back, or jaw pain</li>
<li>chest tightness or heaviness</li>
<li>diarrhea</li>
<li>general feeling or discomfort or illness</li>
<li>increased hunger</li>
<li>increased urination</li>
<li>loss of consciousness</li>
<li>muscle pain</li>
<li>muscle spasm or jerking of all extremities</li>
<li>nausea</li>
<li>no blood pressure or pulse</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>palpitations or pounding in the ears</li>
<li>pounding or racing heartbeat or pulse</li>
<li>slow heartbeat</li>
<li>stopping of the heart</li>
<li>sudden loss of consciousness</li>
<li>trouble sleeping</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of formoterol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Agitation</li>
<li>back pain</li>
<li>increased mucous in the throat and lungs</li>
<li>leg cramps</li>
<li>muscle cramps</li>
<li>redness of the skin</li>
<li>restlessness</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>trembling or shaking of the hands or feet</li>
</ul><p>
<!-- end inhalation capsule, inhalation solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to formoterol: inhalation capsule, inhalation solution</i></p><h3>General</h3><p>Common adverse reaction to Long-acting beta2-adrenergic agonists (LABA) drugs include: Angina, hypertension or hypotension, tachycardia, arrhythmias, nervousness, headache, tremor, dry mouth, palpitation, muscle cramps, nausea, dizziness, fatigue, malaise, hypokalemia, hyperglycemia, metabolic acidosis, and insomnia.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Viral infection (17.2%)</p>
<p><b>Common</b> (1% to 10%): Fever (2.2%), fatigue</p>
<p><b>Very rare</b> (less than 0.01%): Peripheral edema<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Serious asthma exacerbations (acute worsening of asthma resulting in hospitalization) occurred more commonly in patients receiving higher than the recommended dose of this drug than in patients who received placebo.</p>
<p>While most of cases of asthma exacerbation have been in patients with severe or acutely deteriorating asthma, a few have occurred in patients with less severe asthma.  It is not possible to determine from these individual case reports whether this drug contributed to the events.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Upper respiratory tract infection (7.4%) </p>
<p><b>Common</b> (1% to 10%): Serious asthma exacerbations (up to 6.4%), bronchitis (4.6%), pharyngitis (3.5%), chest infection (2.7%), sinusitis (2.7%), dyspnea (2.1%), increased sputum (1.5%) tonsillitis (1.2%), dysphonia (1%), chest pain, cough</p>
<p><b>Uncommon</b> (0.1% to 1%): Bronchospasm, throat irritation (including paradoxical bronchospasm)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash (1.1%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Hyperhidrosis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea (4.9%), vomiting (2.4%), dry mouth, nausea<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain (4.2%), leg cramps (1.7%), muscle cramps</p>
<p><b>Uncommon</b> (0.1% to 1%): Myalgia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, tremor, dizziness</p>
<p><b>Uncommon</b> (0.1% to 1%): Taste disturbances, nervousness</p>
<p><b>Very rare</b> (less than 0.01%): Central nervous system stimulation<sup>[Ref]</sup></p><p>Central nervous system stimulating effects have been sporadically reported following inhalation of beta2-sympathomimetics, manifesting as hyperexcitability.  These effects were mainly observed in children up to 12 years of age.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety (1.5%).  insomnia (1.5%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Sleep disturbances</p>
<p><b>Rare</b> (less than 0.1%): Agitation, restlessness</p>
<p><b>Very rare</b> (less than 0.01%): Abnormal behavior, hallucination<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Tachycardia, palpitations, cardiac arrhythmias (e.g.  atrial fibrillation), supraventricular tachycardia, extrasystoles, angina pectoris</p>
<p><b>Very rare</b> (less than 0.01%): Prolongation of QTc interval, variations in blood pressure</p>
<p><b>Postmarketing reports</b>: Tachyarrhythmia, blood pressure increased (including hypertension)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity reactions (e.g.  bronchospasm, exanthema, urticaria, pruritus)</p>
<p><b>Very rare</b> (less than 0.01%): Angioneurotic edema, edema (including conjunctival irritation and eyelid edema)</p>
<p><b>Postmarketing reports</b>: Anaphylactic reactions, including severe hypotension and angioedema (presenting as face, lip, tongue, eye, pharyngeal, or mouth edema).<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Treatment with beta2-agonists may result in an increase in blood levels of insulin, free fatty acids, glycerol and ketone bodies.<sup>[Ref]</sup></p><p><b>Uncommon</b> (0.1% to 1%): Hypokalemia, hyperglycemia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (less than 0.1%): Nephritis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very rare</b> (less than 0.01%): Thrombopenia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Foradil (formoterol)" Novartis Pharmaceuticals, East Hanover, NJ. </p><p id="ref_4">4. "Product Information. Perforomist (formoterol)." Dey Laboratories, Napa, CA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Perforomist (formoterol)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: adrenergic bronchodilators</li>
<li>FDA Alerts (3)</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Perforomist &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Foradil Aerolizer</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>COPD, Maintenance</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to formoterol: inhalation capsule, inhalation solution</i></p><h3>General</h3><p>Common adverse reaction to Long-acting beta2-adrenergic agonists (LABA) drugs include: Angina, hypertension or hypotension, tachycardia, arrhythmias, nervousness, headache, tremor, dry mouth, palpitation, muscle cramps, nausea, dizziness, fatigue, malaise, hypokalemia, hyperglycemia, metabolic acidosis, and insomnia.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Viral infection (17.2%)</p><p><b>Common</b> (1% to 10%): Fever (2.2%), fatigue</p><p><b>Very rare</b> (less than 0.01%): Peripheral edema<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Serious asthma exacerbations (acute worsening of asthma resulting in hospitalization) occurred more commonly in patients receiving higher than the recommended dose of this drug than in patients who received placebo.</p><p>While most of cases of asthma exacerbation have been in patients with severe or acutely deteriorating asthma, a few have occurred in patients with less severe asthma.  It is not possible to determine from these individual case reports whether this drug contributed to the events.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Upper respiratory tract infection (7.4%) </p><p><b>Common</b> (1% to 10%): Serious asthma exacerbations (up to 6.4%), bronchitis (4.6%), pharyngitis (3.5%), chest infection (2.7%), sinusitis (2.7%), dyspnea (2.1%), increased sputum (1.5%) tonsillitis (1.2%), dysphonia (1%), chest pain, cough</p><p><b>Uncommon</b> (0.1% to 1%): Bronchospasm, throat irritation (including paradoxical bronchospasm)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash (1.1%)</p><p><b>Uncommon</b> (0.1% to 1%): Hyperhidrosis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea (4.9%), vomiting (2.4%), dry mouth, nausea<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain (4.2%), leg cramps (1.7%), muscle cramps</p><p><b>Uncommon</b> (0.1% to 1%): Myalgia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, tremor, dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Taste disturbances, nervousness</p><p><b>Very rare</b> (less than 0.01%): Central nervous system stimulation<sup>[Ref]</sup></p><p>Central nervous system stimulating effects have been sporadically reported following inhalation of beta2-sympathomimetics, manifesting as hyperexcitability.  These effects were mainly observed in children up to 12 years of age.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety (1.5%).  insomnia (1.5%)</p><p><b>Uncommon</b> (0.1% to 1%): Sleep disturbances</p><p><b>Rare</b> (less than 0.1%): Agitation, restlessness</p><p><b>Very rare</b> (less than 0.01%): Abnormal behavior, hallucination<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Tachycardia, palpitations, cardiac arrhythmias (e.g.  atrial fibrillation), supraventricular tachycardia, extrasystoles, angina pectoris</p><p><b>Very rare</b> (less than 0.01%): Prolongation of QTc interval, variations in blood pressure</p><p><b>Postmarketing reports</b>: Tachyarrhythmia, blood pressure increased (including hypertension)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity reactions (e.g.  bronchospasm, exanthema, urticaria, pruritus)</p><p><b>Very rare</b> (less than 0.01%): Angioneurotic edema, edema (including conjunctival irritation and eyelid edema)</p><p><b>Postmarketing reports</b>: Anaphylactic reactions, including severe hypotension and angioedema (presenting as face, lip, tongue, eye, pharyngeal, or mouth edema).<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Treatment with beta2-agonists may result in an increase in blood levels of insulin, free fatty acids, glycerol and ketone bodies.<sup>[Ref]</sup></p><p><b>Uncommon</b> (0.1% to 1%): Hypokalemia, hyperglycemia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (less than 0.1%): Nephritis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very rare</b> (less than 0.01%): Thrombopenia<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Foradil (formoterol)" Novartis Pharmaceuticals, East Hanover, NJ. </p><p id="ref_4">4. "Product Information. Perforomist (formoterol)." Dey Laboratories, Napa, CA. </p><h2>More about Perforomist (formoterol)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: adrenergic bronchodilators</li>
<li>FDA Alerts (3)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Perforomist &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>COPD, Maintenance</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>